Glycover 0.2mg Injection
By Glycover
Rx
1ml Injection in a Vial
Composition
Glycopyrrolate(0.2mg)
Manufacturer - Verve Healthcare Ltd
VERVE HEALTH CARE LTD., A-43, (Basement), G.T. Karnal Road Indl. Area, New Delhi - 110033 (INDIA)
Expires on or after
July, 2025
Limited information is accessible regarding the use of Glycover 0.2mg Injection in patients with liver disease. It is advisable to consult your doctor for appropriate guidance and potential risks associated with the injection.
Caution should be taken when using Glycover 0.2mg Injection in patients with kidney disease. It may require dose adjustment. Please consult your doctor for guidance.
Consult your doctor when consuming alcohol with Glycover 0.2mg Injection.
Glycover 0.2mg Injection may impact vision and coordination, possibly affecting your driving skills. Be cautious as these side effects could hinder your ability to drive safely.
Glycover 0.2mg Injection is believed to be safe during pregnancy based on animal studies. Limited human studies are available, showing low risk to the baby.
Glycover 0.2mg Injection appears safe during breastfeeding. Limited data shows no significant risk to the baby. Long-term use may decrease milk production.
Habit Forming | No |
Chemical Class | Synthetic Quaternary Ammonium |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Anticholinergic - Anaesthesia |
₹13.5
Inclusive of all taxes
Content verified by
Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024